2-Naphthalenesulphanyl-L-aspartyl-2-(phenethyl) amide (2-NAP) and food intake in rats: evidence that endogenous peripheral CCK does not play a major role as a satiety factor

scientific article published on November 1995

2-Naphthalenesulphanyl-L-aspartyl-2-(phenethyl) amide (2-NAP) and food intake in rats: evidence that endogenous peripheral CCK does not play a major role as a satiety factor is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1476-5381.1995.TB15082.X
P932PMC publication ID1909058
P698PubMed publication ID8581271
P5875ResearchGate publication ID14619812

P2093author name stringEbenezer IS
Baldwin BA
P2860cites workBiochemical and pharmacological characterization of an extremely potent and selective nonpeptide cholecystokinin antagonistQ35615494
Functional role of brain CCK receptorsQ37278765
Cholecystokinin suppresses sham feeding in the rhesus monkeyQ39706178
Biological actions of cholecystokininQ40638002
Satiating effect of cholecystokininQ40753289
Endogenous cholecystokinin reduces feeding in young ratsQ41227039
Effects of the CCK receptor antagonist MK-329 on food intake in pigsQ41227828
C-terminal octapeptide of cholecystokinin decreases food intake in man.Q41550216
Cholecystokinin and satiety in pigsQ41550818
2‐Naphthalenesulphonyl l‐aspartyl‐(2‐phenethyl)amide (2‐NAP)‐a selective cholecystokinin CCKA‐receptor antagonistQ41866496
The cholecystokinin receptor antagonist L364,718 increases food intake in the rat by attenuation of the action of endogenous cholecystokininQ42849467
Hunger in humans induced by MK-329, a specific peripheral-type cholecystokinin receptor antagonist.Q45977303
Penetration of diazepam and the non-peptide CCK antagonist, L-364,718, into rat brainQ48202715
Effect of a novel CCKA receptor antagonist (2-NAP) on the reduction in food intake produced by CCK in pigsQ48206693
Increased food intake after type A but not type B cholecystokinin receptor blockadeQ48867641
The effect of intracerebroventricular administration of baclofen on food intake in ratsQ48913210
Rapid appearance of intraventricularly administered neuropeptides in the peripheral circulationQ48933411
A70104 and food intake in pigs: implication for the CCK 'satiety' hypothesis.Q52225149
Cholecystokinin decreases food intake in rats.Q52320733
Cholecystokinin receptors and vagal nerves in control of food intake in rats.Q54100797
Postponement of satiety by blockade of brain cholecystokinin (CCK-B) receptorsQ60054766
Hormonal control of avian pancreas by gastrin-releasing peptide from the proventriculusQ67924348
Satiety induced by endogenous and exogenous cholecystokinin is mediated by CCK-A receptors in miceQ68098805
Intravenous injections of cholecystokinin and caerulein suppress food intake in domestic fowlsQ71330061
Effects of the CCK receptor antagonist MK-329 on food intake in broiler chickensQ72201000
Blockade of type A, but not type B, CCK receptors postpones satiety in rhesus monkeysQ72542574
P433issue5
P407language of work or nameEnglishQ1860
P921main subjectsatietyQ1562684
P304page(s)2371-2374
P577publication date1995-11-01
P1433published inBritish Journal of PharmacologyQ919631
P1476title2-Naphthalenesulphanyl-L-aspartyl-2-(phenethyl) amide (2-NAP) and food intake in rats: evidence that endogenous peripheral CCK does not play a major role as a satiety factor
P478volume116

Reverse relations

cites work (P2860)
Q490596052-NAP, a peripheral CCK-A receptor antagonist, modulates the development of a preference for the mother by the newborn lamb
Q73378791Does increased endogenous CCK interact with serotonin to reduce food intake in rats?
Q74085776Effects of intracerebroventricular administration of the CCK(1) receptor antagonist devazepide on food intake in rats
Q28578998Effects of peripheral CCK receptor blockade on feeding responses to duodenal nutrient infusions in rats
Q44435084Effects of peripheral CCK receptor blockade on food intake in rats
Q46621640Electrophysiological responses of nucleus tractus solitarius neurons to CCK and gastric distension in newborn lambs
Q47819141Food for thought: a critique on the hypothesis that endogenous cholecystokinin acts as a physiological satiety factor
Q36094371PEGylated cholecystokinin prolongs satiation in rats: dose dependency and receptor involvement
Q48102294Relative blood-brain barrier permeabilities of the cholecystokinin receptor antagonists devazepide and A-65186 in rats
Q48388438The effects of a peripherally acting cholecystokinin1 receptor antagonist on food intake in rats: implications for the cholecystokinin-satiety hypothesis

Search more.